These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32803990)

  • 1. Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Khan JN; Singh A; Gulsin GS; Chan DCS; Cheng ASH; Yang J; Li Z; Gupta P; Squire IB; McCann GP; Ng LL
    Biomarkers; 2020 Nov; 25(7):556-565. PubMed ID: 32803990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The partnership between renalase and ejection fraction as a risk factor for increased cardiac remodeling biomarkers in chronic heart failure patients.
    Stojanovic D; Mitic V; Stojanovic M; Petrovic D; Ignjatovic A; Stefanovic N; Cvetkovic T; Kocic G; Bojanic V; Deljanin Ilic M
    Curr Med Res Opin; 2020 Jun; 36(6):909-919. PubMed ID: 32297799
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.
    Menghoum N; Badii MC; Deltombe M; Lejeune S; Roy C; Vancraeynest D; Pasquet A; Gerber BL; Horman S; Gruson D; Beauloye C; Pouleur AC
    ESC Heart Fail; 2024 Jun; 11(3):1493-1505. PubMed ID: 38339764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.
    Rabkin SW; Tang JKK
    Heart Fail Rev; 2021 Jul; 26(4):799-812. PubMed ID: 32472523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast-growth-factor-23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes.
    Kanagala P; Arnold JR; Khan JN; Singh A; Gulsin GS; Eltayeb M; Gupta P; Squire IB; McCann GP; Ng LL
    ESC Heart Fail; 2020 Dec; 7(6):4089-4099. PubMed ID: 32935918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study.
    Kanagala P; Squire IB; Jones DJL; Cao TH; Chan DCS; McCann G; Sandhu JK; Quinn PA; McAdam J; Marsh AM; Davies JE; Struck J; Bergmann A; Sabti Z; Twerenbold R; Herrmann T; Kozhuharov N; Mueller C; Ng LL;
    Clin Res Cardiol; 2019 Aug; 108(8):940-949. PubMed ID: 30767059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
    Huerta A; López B; Ravassa S; San José G; Querejeta R; Beloqui Ó; Zubillaga E; Rábago G; Brugnolaro C; Díez J; González A
    J Hypertens; 2016 Jan; 34(1):130-8. PubMed ID: 26575701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction.
    Yogasundaram H; Nikhanj A; Putko BN; Boutin M; Jain-Ghai S; Khan A; Auray-Blais C; West ML; Oudit GY
    J Am Heart Assoc; 2018 Nov; 7(21):e009098. PubMed ID: 30571380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.